Mingping Zhang

With 20 years of Chinese chemistry, manufacturing, and controls (CMC) and regulatory experience, Mingping is responsible for providing China regulatory and CMC consulting services, including global-to-China and China-to-global strategies and CMC gap analysis for China registration. Mingping has held numerous regulatory strategy positions including CMC reviewer, CFDA; vice president, Suzhou Ribo; regulatory CMC manager, Novartis; CMC director, BeiGene; R&D-based Pharmaceutical Association Committee council member; CMC Focus Group member; chair of ISPE China Regulatory & Compliance Committee; and associate chair of ISPE China.

Education

He holds a master’s degree in chemical engineering from National University of Singapore and a bachelor’s degree in biochemical engineering from Beijing University.